Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
CID-103 is a monoclonal antibody that binds CD38, a cell surface glycoprotein expressed on tumor cells, potentially resulting in antibody-dependent cellular cytotoxicity (ADCC) and tumor cell lysis (NCI Drug Dictionary).
|DrugClasses||CD38 Antibody 17|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|